Results 11 to 20 of about 31,914 (284)

Non-vitamin K antagonist oral anticoagulants for heart diseases [PDF]

Терапевтический архив, 2017
Non-vitamin K antagonist oral anticoagulants (NОАСs) are highly effective drugs that prevent venous thrombosis and stroke in atrial fibrillation. Their use has difficulties that are associated with the need for laboratory control and with the influence ...
T B Kondratieva, L V Popova, I N Bokarev
doaj   +3 more sources

Non-vitamin K antagonist oral anticoagulants for COVID-19 thrombosis

Journal of Acute Disease, 2022
Thrombotic complications appear to be a major predictor of death in COVID-19 patients, and multiple studies have shown that anticoagulants can help to improve the outcome.
Adel Khalifa Sultan Hamad
doaj   +2 more sources

Vitamin K and Bone Health: A Review on the Effects of Vitamin K Deficiency and Supplementation and the Effect of Non-Vitamin K Antagonist Oral Anticoagulants on Different Bone Parameters

Journal of Osteoporosis, 2019
Although known for its importance in the coagulation cascade, vitamin K has other functions. It is an essential vitamin for bone health, taking part in the carboxylation of many bone-related proteins, regulating genetic transcription of osteoblastic ...
Celia Rodríguez-Olleros Rodríguez, Manuel Díaz Curiel   +1 more
doaj   +2 more sources

The safety of new oral anticoagulants for ischemic stroke and systemic embolism prevention in females with atrial fibrillation [PDF]

Romanian Journal of Neurology, 2021
The prevalence of atrial fibrillation is lower in females than in men, but the risk of stroke and systemic thromboembolism is comparable or even higher. Administration of anticoagulant therapy does not modify this difference. Two classes of non-vitamin K
Despina-Manuela Toader, Ileana Neaca, Alina Paraschiv, Rodica Musetescu   +3 more
doaj   +1 more source

Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis

Anatolian Journal of Cardiology, 2022
Background: The meta-analysis of randomized controlled trials has illustrated that the efficacy of low-dose non-vitamin K antagonist oral anticoagulants is inferior compared with standard-dose non-vitamin K antagonist oral anticoagulants, though they are
Zei Li, Yingming Zheng, Dandan Li, Xiaozhen Wang, Sheng Cheng, Xiao Luo, Aiping Wen   +6 more
doaj   +1 more source

Progress in the Application of Oral Anticoagulants in Patients with Non-valvular Atrial Fibrillation and Chronic Renal Insufficiency

Xiehe Yixue Zazhi, 2022
Oral anticoagulants can effectively reduce the risk of stroke in patients with atrial fibrillation. However, patients with atrial fibrillation and chronic renal insufficiency have an increased risk in both stroke and bleeding, making anticoagulant ...
LI Xin, LIU Lu, LIU Zhihong, ZHAO Zhihui, LUO Qin, ZHAO Qing   +5 more
doaj   +1 more source

Non-Vitamin K Antagonist Oral Anticoagulants in Differentiated Approach to the Use in Cardiological Practice: Literature Review

Український журнал серцево-судинної хірургії, 2023
Non-vitamin K antagonist oral anticoagulants (novel oral anticoagulants, NOACs) are important pharmaceuticals for prevention of stroke and systemic embolism in non-valvular atrial fibrillation patients.
Larysa A. Vozniuk, Olga V. Dzekan, Sergii O. Siromakha   +2 more
doaj   +1 more source

Safety and differences between direct oral anticoagulants and vitamin K antagonists in the risk of post-traumatic intrathoracic bleeding after rib fractures in elderly patients

Emergency Care Journal, 2021
Closed chest traumas are frequent consequences of falls in the elderly. The presence of concomitant oral anticoagulant therapy can increase the risk of post-traumatic bleeding even in cases of trauma with non-severe dynamics. There is limited information
Gianni Turcato, Arian Zaboli, Andrea Tenci, Giorgio Ricci, Massimo Zannoni, Christoph Scheurer, Anton Wieser, Antonio Maccagnani, Antonio Bonora, Norbert Pfeifer   +9 more
doaj   +1 more source

Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase.

Journal of the American Medical Association (JAMA), 2022
Importance Current guidelines recommend against use of intravenous alteplase in patients with acute ischemic stroke who are taking non-vitamin K antagonist oral anticoagulants (NOACs).
Wayneho Kam, D. Holmes, Adrian F. Hernandez, J. Saver, G. Fonarow, Eric E. Smith, Deepak L. Bhatt, L. Schwamm, M. Reeves, Roland A. Matsouaka, Yosef M. Khan, M. Unverdorben, M. Birmingham, P. Lyden, A. Asimos, Dorothea Altschul, Tim L. Schoonover, M. Jumaa, J. Nomura, M. Suri, S. Moore, E. Lafranchise, Daiwai M. Olson, E. Peterson, Y. Xian   +24 more
semanticscholar   +1 more source

Changes in primary care management of atrial fibrillation patients following the shift from warfarin to non-vitamin K antagonist oral anticoagulants: a Norwegian population based study

BMC Primary Care, 2022
Background To assess baseline characteristics, drug utilisation and healthcare use for oral anticoagulants (OACs) following the introduction of non-vitamin K antagonist oral anticoagulants among patients with atrial fibrillation in primary care in Norway.
Sigrun Halvorsen, Jørgen Anton Smith, Fabian Söderdahl, Marcus Thuresson, Oddvar Solli, Maria Ulvestad, Christian Jonasson   +6 more
doaj   +1 more source